Clinical Trials Directory

Trials / Enrolling By Invitation

Enrolling By InvitationNCT06476288

RIC (Remote Ischemic Conditioning) in Older Individuals

Feasibility and Acceptability of Remote Ischemic Conditioning to Achieve High-Intensity Rehabilitation Effects and Increase Resilience in Older Individuals

Status
Enrolling By Invitation
Phase
N/A
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
Duke University · Academic / Other
Sex
All
Age
65 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to examine the feasibility and acceptability of a technique called remote ischemic conditioning (RIC) that aims to improve muscle strength, muscle mass, exercise tolerance, resilience (i.e. how well someone responds to a stressor), quality of life, physical activity, and physical function when added to rehabilitative exercise training in individuals over age 65 who have some difficulty with mobility.

Conditions

Interventions

TypeNameDescription
OTHERLow-intensity resistance exercise trainingThe intervention protocol will consist of 60 minutes of low-intensity resistance exercise training 3x/week for 6 weeks.
OTHERHigh-Dose Remote ischemic conditioning (RIC)Treatment dose of RIC- the RIC cuff will be inflated to 20 mmHg over the participant's systolic blood pressure. The treatment dose of RIC will be applied in 4 sets of cycles with inflating the cuff and leaving it pumped for 5 minutes then deflating the cuff for an off period of 5 minutes. Total treatment time will be 35 minutes.
OTHERLow-Dose Remote ischemic conditioning (RIC)This dose will be the control for the study. Low-dose RIC- the RIC cuff will be inflated to 10 mmHg below the participant's diastolic blood pressure. The low-dose RIC will be applied in 4 sets of cycles with inflating the cuff and leaving it pumped for 5 minutes then deflating the cuff for an off period of 5 minutes. Total treatment time will be 35 minutes.

Timeline

Start date
2024-09-30
Primary completion
2026-06-01
Completion
2026-07-01
First posted
2024-06-26
Last updated
2025-12-16

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06476288. Inclusion in this directory is not an endorsement.